Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin. (Q50914657)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2007

Language	Label	Description	Also known as
English	Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin.	scientific article published in July 2007

Statements

scholarly article

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin. (English)

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

1 reference

based on heuristic

inferred from title

author name string

R Schiaffini

1

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

P I Patera

2

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

C Bizzarri

3

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

P Ciampalini

4

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

M Cappa

5

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

publication date

1 July 2007

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

30

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

7

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

572-577

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

https://scigraph.springernature.com/pub.10.1007/bf03346351

0 references

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Insulin pump use in young adolescents with type 1 diabetes: a descriptive study.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Physiological insulin replacement in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Insulin Pharmacokinetics

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

A comparison of basal insulin delivery: continuous subcutaneous insulin infusion versus glargine

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Insulin glargine: an updated review of its use in the management of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

1 reference

https://api.crossref.org/works/10.1007%2FBF03346351

21 January 2018

Insulin glargine: a new long-acting insulin product.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabet

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premeal insulin treatment during basal-bolus regimen in young children with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive insulin treatment in diabetic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified Insulin Therapy in the Type I Diabetic Adolescent: A Controlled Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin formulation and delivery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

To pump or not to pump

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse events in intensively treated children and adolescents with type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/17848840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03346351

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

1 reference

Europe PubMed Central

25 March 2018

http://europepmc.org/abstract/MED/17848840

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50914657&oldid=2171222477"